The DOI matches its Crossref record.
10.23812/j.biol.regul.homeost.agents.20243804.256
Open accessAbstract
Background: Osteosarcoma (OS) is the most prevalent primary malignant bone tumor among adolescents, yet the efficacy of current medications is limited by a lack of understanding of the molecular mechanisms underpinning OS growth and metastasis. In previous studies, cantharidin (CTD), an effective component found in several clinical traditional Chinese medicine formulations, has demonstrated promising pharmacological efficacy against various malignancies. However, the precise biological functions and regulatory mechanisms of CTD in OS, particularly its interaction with the Forkhead box O3A (FOXO3A)/Methyltransferase Like 14 (METTL14)/Type III Intermediate Filament Protein (Vimentin) pathway, remain incompletely understood, warranting further investigation. Methods: Eighteen female BALB/c nude mice (four-week-old; 15 ± 2 g) were utilized in this study and divided into three groups (n = 6/group): Normal control, Control, and CTD groups. Mice in the Normal control group received saline injections, while those in the other groups were injected with U-2 OS cells at the proximal end of the left tibia to establish an osteosarcoma model. Following successful model establishment, mice in the Control group received a daily intraperitoneal injection of saline (1 mg/kg), while those in the CTD group received an intraperitoneal injection of CTD (2.5 mg/kg). The inhibitory effect of CTD on tumor growth was evaluated after 28 days of continuous treatment. Additionally, the effects of CTD on OS cells were assessed using a Cell Counting Kit-8 (CCK-8), colony formation, and Transwell assays. Western blotting and quantitative real-time PCR (qRT-PCR) were employed to quantify FOXO3A/METTL14 expression levels. Results: Lower levels of FOXO3A expression were observed in OS tissues ( p < 0.01), with these expression levels significantly correlating with OS patient prognosis ( p < 0.01). Compared to controls, CTD significantly suppressed osteosarcoma cell growth and metastasis as well as tumor growth ( p < 0.001) by activating the FOXO3A/METTL14 pathway, consequently downregulating Vimentin expression ( p < 0.001). Conclusion: Our findings indicate that cantharidin restricts osteosarcoma cell proliferation and metastasis through modulation of the FOXO3A/METTL14/Vimentin pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Production and processing of graphene and related materials
Backes, C., Abdelkader, A. M., Alonso, C., Andrieux-Ledier, A., Arenal, R., Azpeitia, J., Balakrishnan, N., Banszerus, L., Barjon, J., Bartali, R., et al. (2020) · 2D Materials · doi:10.1088/2053-1583/ab1e0a · Cited by 501
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
Yarom, N., Shapiro, C. L., Peterson, D. E., Van Poznak, C. H., Bohlke, K., Ruggiero, S. L., Migliorati, C. A., Khan, A., Morrison, A., Anderson, H., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01186 · Cited by 420
Surface plasmon resonance (SPR) biosensors for food allergen detection in food matrices
Zhou, J., Qi, Q., Wang, C., Qian, Y., Liu, G., Wang, Y., & Fu, L. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111449 · Cited by 350
Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches
Park, K.-H., & Park, W. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.9.1213 · Cited by 327
Metadata
- Venue
- JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
- Published
- 2024-04-01
- Volume
- 38
- Issue
- 4
- ISSN
- 0393-974X (ISSN-L)
- OpenAlex
- W4407292618
- Cited by
- 500
- References
- 0
- FWCI
- 52.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 10.23812/j.biol.regul.homeost.agents.20243804.256. https://app.cochat.ai/papers/10.23812/j.biol.regul.homeost.agents.20243804.256
- The paper
- 10.23812/j.biol.regul.homeost.agents.20243804.256. (2024). JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. https://doi.org/10.23812/j.biol.regul.homeost.agents.20243804.256
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.